Stockreport

Cognition Therapeutics to Report Fourth Quarter and Full Year 2024 Results

Cognition Therapeutics, Inc.  (CGTX) 
PDF PURCHASE, N.Y., March 13, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical stage company developing product candidates that treat neuro [Read more]